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What does a cell have in common with a thriving 
business? More than you might think says Dr Stefan 
Klumpp – and its all down to the economic principles 
of physiological decision-making
I
n high school textbooks, cells are often compared to fac-
tories that contain a plethora of different machines, power 
plants and delivery systems. Growing and proliferating cells 
have to make all these machines for their daughter cells, so 
taking the metaphor of the cell as a factory a step further, 
one can compare them to an expanding company that has to 
make investment decisions. A key investment decision in rapidly 
growing cells (bacteria and yeast, but possibly also proliferating 
mammalian cells) is how to use the cell’s ribosomes. Cell growth 
and proliferation is closely linked to protein synthesis, because 
growing cells have to make large amounts of protein. For exam-
ple, in rapidly growing bacteria, half of the cell’s mass is protein 
and protein synthesis accounts for up to two-thirds of the cell’s 
energy consumption. In exponential growth, all cellular protein 
needs to be doubled within one doubling time, so the molecular 
machines that power protein synthesis, the ribosomes, have to 
work at a very high rate. 
The most striking evidence for the close link between cell growth 
and protein synthesis is the perfectly linear relationship between 
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the cellular ribosome concentration and the growth rate, which 
was discovered based on the systematic characterisation of bac-
terial growth and its effect on the cells’ chemical composition in 
the late 50s. For example, E. coli cells have been grown in differ-
ent growth media that contain different nutrients and for each 
medium the growth rate and the ribosome concentration was 
measured. If the ribosome concentration is plotted against the 
growth rate, a very simple linear correlation is found (Figure 1), 
despite the fact that the regulation of ribosome synthesis is very 
complex. The linear relation can be interpreted as reflecting the 
autocatalytic activity of ribosomes making ribosomal proteins. 
Thus, at rapid growth, cells devote more ribosomes to making 
ribosomal protein than at slow growth. This idea has been de-
veloped into a quantitative theoretical description of cellular 
resource allocation by Matt Scott et al. in an article published 
in Science in 2010, realising that the cell has to balance conflict-
ing requirements1. It would be advantageous for cell growth if 
the cell could devote a fraction of ribosomes as large as possible 
to making ribosomal proteins, but devoting many ribosomes to 
making enzymes that import and process nutrients is also advan-
tageous for cell growth. The two fractions cannot be maximised 
at the same time, but rather the cell has to find a balance between 
these requirements. Using another concept from economic the-
ory, this balance has recently been interpreted as a case of Pareto 
optimality, where any improvement of one objective results in a 
setback for another objective2. 
In industrial production, companies can react to a slow-down 
in demand either with lay-offs or by reducing the workload 
(working hours) per worker. Cells facing a slow-down of nutrient 
availability have the corresponding choices with their ribosomes. 
They can reduce the ribosome concentration or make the 
ribosomes work at a lower rate. Likewise, they can react to an 
improvement of the growth conditions by increasing the ribosome 
concentration or by increasing the rate at which ribosomes work. 
It turns out that E coli uses a combination of the two strategies, 
increasing or decreasing ribosome concentration and translation 
speed together. Which strategy is used was the subject of a 
long-standing controversy, as the linear relationship between 
growth rate and ribosome concentration has traditionally been 
interpreted in terms of a constant translation speed, inconsistent 
with direct observations. However, recent analysis has shown that 
the two are indeed consistent if the interpretation of the linear 
relation is slightly modified3. 
From the viewpoint of economic allocation of ribosomes, the 
modulation of the translation speed indicates that high transla-
tion speed also comes at a cost for the cell. Otherwise the big 
investment that is the cellular ribosome pool would be used quite 
inefficiently, as the ribosomes could work at higher speed without 
additional cost. Indeed, a cost can be attributed to the transla-
tion speed, because high rates of translation require additional 
proteins to be synthesised. The most important of these is elonga-
tion factor Tu (EF-Tu), which delivers tRNAs carrying the amino 
acids needed for protein chain elongation to the ribosome. EF-
Tu is the most abundant protein in rapidly growing E. coli cells, 
where it can account for up to 10% of 
the total protein mass. This means that 
the cell again has to balance different 
requirements, making many ribo-
somes and making them fast, that 
cannot both be optimally satis-
fied at the same time. A recent 
theoretical analysis3 of that bal-
ance shows that a simple strate-
gy for almost optimal use of the 
cellular resources is to couple 
the speed-related proteins such 
as EF-Tu and tRNA synthetases 
closely to the ribosomes and to 
increase their synthesis when-
ever the ribosome synthesis is 
increased. Indeed, in bacteria the 
genes encoding these proteins as 
well as the tRNAs are often located in 
operons together with ribosomal com-
ponents and thus regulated in a similar 
fashion.
Why is it costly for the cell to increase the speed of 
translation? Rapid translation requires that EF-Tu delivers 
tRNAs carrying the amino acids to the ribosome at a high rate. 
This rate, however, is limited by a physical constraint. The cyto-
plasm is a crowded place, filled with proteins and other macro-
molecules, and therefore diffusion of the big complexes of EF-Tu 
and tRNA is quite slow. The only way to make them arrive faster 
is to have lots of them, so one of them may get to the ribosome 
in time. 
Understanding the economic strategies of how to allocate ribo-
somes to making different types of proteins is not only interesting 
as a basic research question. For example, in biotechnology, bac-
teria are often used for the recombinant expression of heterolo-
gous proteins. From the point of view of the bacteria, this task is 
not much more than a gigantic waste of ribosomal resources and 
thus leads to a slow-down of growth that becomes more and more 
pronounced with increasing levels of expression of the ‘unneces-
sary’ protein. Thus, taking into account the internal economic 
principles of the cell may help increase the yield of expression. 
Moreover, aspects of the proteomic economics may be useful for 
understanding the action of antibiotics and improving treatment 
strategies. Bacterial ribosomes are the target of a large number 
of antibiotics. Typically the cells react to such drugs by making 
more ribosomes to partly compensate the reduced ribosome 
function (provided that the dose is sufficiently low to not kill the 
cells immediately). Other types of antibiotics lead to different re-
sponses, for example drugs targeting DNA replication. Combin-
ing antibiotics that induce conflicting responses has been pro-
posed as a strategy to enhance the cooperative effect of the two 
drugs4. For example, ribosome synthesis is down-regulated when 
DNA replication is impaired. This down-regulation prevents the 
compensation for reduced ribosome function if a ribosome drug 
is administered in addition to a drug targeting DNA replication. 
Thus, one drug (blocking DNA replication) effectively makes the 
cells more susceptible to the second drug (targeting ribosomes). 
In effect, low doses of the two drugs may have a stronger effect 
than a high dose of either antibiotic alone. 
Economic constraints such as those discussed here for ribo-
some synthesis and function apply to many physiological situ-
ations, so similar approaches can be expected to be fruitful for 
other problems as well. Indeed, a recent study has addressed the 
coordination of the carbon and nitrogen metabolism based on 
considering the growth-rate dependent expression of the cor-
responding enzymes5. Approaches of this type that combine the 
quantitation of cell growth with economic considerations of the 
proteome can tame the complexity of the underlying molecular 
control by directly addressing physiological responses rather 
than the multiplicity of molecular interactions. Moreover, similar 
considerations can be applied to all kinds of cells, as long as they 
are rapidly growing and proliferating, so similar studies should 
provide insight into the economic principles used by proliferat-
ing cells in higher organisms, in particular during embryonic 
development or in tumours. 
Figure 1: Relation between ribosome concentration and growth rate for 
E. coli grown in media with different nutrients.
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